| ef5b4a8f-5c0a-4361-b203-bc27d6f3a30c | Efeitos adversos de trombolíticos | Y445 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11522 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 5bcd8f32-2276-4a61-97a6-dbf426529d91 | Efeitos adversos do sangue natural e produtos do sangue | Y446 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11523 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 8b8d59ab-a9f4-4b0b-990d-3b656572f3d8 | Efeitos adversos de substitutos do plasma | Y447 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11524 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 8d322fd1-d511-4f19-80a5-7f8c906ad9a2 | Efeitos adversos de outras subst. farmac. que atuam sobre os constit. do sangue e as ñ especificadas | Y449 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11525 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 833861ed-871a-4f63-9ae4-5d28689e419f | Efeitos adversos de substancias analgesicas antipireticas e antiinflamatórias | Y45 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14109 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| 430a8a8d-d427-459f-b113-147f485b0cb4 | Efeitos adversos de opiáceos e analgésicos correlatos | Y450 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11526 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| fbe88615-a945-40fc-b987-b10909c8e6a1 | Efeitos adversos de salicilatos | Y451 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11527 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 0cbd2f01-7661-4bc7-9759-7ef55900456e | Efeitos adversos de derivados do ácido propiônico | Y452 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11528 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 15a3ad51-5da9-4d83-b15c-926596e07d08 | Efeitos adversos de outras drogas antiinflamatórias não-esteróides | Y453 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11529 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 069e85d3-c834-40e9-8481-cf3a0413bf55 | Efeitos adversos de anti-reumáticos | Y454 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11530 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 635ea2ae-7eb5-43e0-9d1c-2fd3aa8478d9 | Efeitos adversos de derivados do 4-aminofenol | Y455 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11531 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| e212ccca-2b65-4481-b3a6-f5e4f0654b92 | Efeitos adversos de outros analgésicos e antipiréticos | Y458 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11532 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| fcbe6773-b802-4f95-8308-528aa6071e59 | Efeitos adversos de substâncias analgésicas e antipiréticas não especificadas | Y459 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11533 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 2157ea6b-5f6a-4a7c-932f-a4319a62ecc1 | Efeitos adversos de drogas anticonvulsivantes (anti-epilepticas) e antiparkinsonianas | Y46 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14110 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| e8f14854-4880-451d-aab4-0b35b6b946a9 | Efeitos adversos de succimidas | Y460 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11534 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 2f7d9d81-357c-4679-a32f-5ebc2cd33cbf | Efeitos adversos de oxazolidínas | Y461 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11535 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| c2e86c2b-f128-4055-86a5-9e281abd2742 | Efeitos adversos de derivados da hidantoína | Y462 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11536 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| e6939c51-bd89-4d27-acc7-d63077ea8840 | Efeitos adversos de desoxibarbitúricos | Y463 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11537 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| acbd90a2-7771-43df-9bce-5c34bf75457f | Efeitos adversos de hormonios e seus substitutos sintéticos e antagonistas ncop | Y42 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14106 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| 6ecfa121-befa-47b1-90c0-d6a89e1bf207 | Efeitos adversos de drogas antitireoidianas | Y422 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11500 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| c2d9bd06-25be-4850-ac59-ca5bc98dd081 | Efeitos adversos de substâncias miorrelaxantes (anti-espásticas) | Y468 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11542 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 766264f8-12c9-4bb1-9a95-fcf6f197ef97 | Efeitos adversos de sedativos hipnóticos e tranquilizantes (ansioliticos) | Y47 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14111 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| 1a7a77e7-ac5c-4399-a4c7-941bad6ba0e1 | Efeitos adversos de barbitúricos, não classificados em outra parte | Y470 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11543 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 353bd407-8dd6-4da7-b8b1-7d2abff18723 | Efeitos adversos de derivados do cloral | Y472 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11545 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| acba1083-20d1-4120-b818-4752d5e0ce9f | Efeitos adversos de paraldeído | Y473 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11546 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| ed06b7af-6255-4e21-b572-3929a3f7ae19 | Efeitos adversos de compostos de bromo | Y474 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11547 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 00b6df96-7389-40de-863f-e723555b90ad | Efeitos adversos de outros sedativos, hipnóticos e tranquilizantes [ansiolíticos] | Y478 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11549 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| bb150d82-500f-478c-993b-5eedce09645e | Efeitos adversos de sedativos, hipnóticos e tranquilizantes [ansiolíticos], não especificados | Y479 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11550 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| ac25d70a-2799-422b-b45f-37f9e809aab3 | Efeitos adversos de anestésicos e gases terapêuticos | Y48 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14112 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| 39c4881f-aeee-4675-9115-8d2a125eed84 | Efeitos adversos de anestésicos por inalação | Y480 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11551 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 515a3850-3a68-4f4f-a1ba-5198037207a7 | Efeitos adversos de anestésicos por via parenteral | Y481 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11552 | 1 | 2021-05-25T19:40:03.671000+00:00 | 2021-05-25T19:40:03.671000+00:00 |
| e869f61e-471c-4ff5-b299-8dd8e98f92e6 | Efeitos adversos de outros anestésicos gerais e os não especificados | Y482 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11553 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| c0c30d84-0c5f-498f-a1f4-7edfcaa25f51 | Efeitos adversos de anestésicos locais | Y483 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11554 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 7accae0b-d11d-4176-8039-a9c4d3d426b2 | Efeitos adversos de anestésico, não especificado | Y484 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11555 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| c4edc50f-7d01-4b74-b7ae-cab30e10ae62 | Efeitos adversos de gases terapêuticos | Y485 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11556 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 2740a605-2613-4ecc-80ad-e989bd6fe0d6 | Efeitos adversos de substancias psicotropicas não classificadas em outra parte | Y49 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14113 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| d0876ccc-cdd6-40e5-a87e-f4cb5590bfab | Efeitos adversos de antidepressivos triciclos e tetracíclicos | Y490 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11557 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| fc1d2044-c6b1-4dcc-9634-e818b48f10a6 | Efeitos adversos de antidepressivos inibidores da mono-amino-oxidase | Y491 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11558 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 3fdb5a3f-2ff3-492d-ace1-f96644a12a34 | Efeitos adversos de outros antidepressivos e os não especificados | Y492 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11559 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| a2a9c9b4-275e-4d43-b221-fbcce7f6b9ee | Efeitos adversos de antipsicóticos e neurolépticos fenotiazínicos | Y493 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11560 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| a16dfc92-1460-455a-be4a-d9b6702dea63 | Efeitos adversos de neurolépticos a base da butirofenona e do tioxanteno | Y494 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11561 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| c106f745-a43a-485e-b36c-e260fd16b838 | Efeitos adversos de outros antipsicóticos e neurolépticos | Y495 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11562 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 19125f8b-3a53-4e2e-a7a9-438b8ffe87a4 | Efeitos adversos de psicodislépticos [alucinógenos] | Y496 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11563 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| c18c4acc-0faf-4920-a474-09dbb4313c18 | Efeitos adversos de psicoestimulantes que podem provocar dependência | Y497 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11564 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| a920d2c4-9cde-463d-9176-9057dac92c92 | Efeitos adversos de outras substâncias psicotrópicas, não classificados em outra parte | Y498 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11565 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| f5f9d28c-66ba-4c0e-96f9-2a0cd0b136d8 | Efeitos adversos de substância psicotrópica, não especificada | Y499 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11566 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 4f93fc66-911c-4629-9bb7-8de76d302adb | Efeitos adversos de estimulantes do sistema nervoso central não classificados em outra parte | Y50 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14114 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| 894ce492-5cdf-46d3-a4fe-165cf30ae6ea | Efeitos adversos de analépticos | Y500 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11567 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 13f5f5c0-8767-4cd4-b568-55bd68c61693 | Efeitos adversos de antagonistas de receptores dos opiáceos | Y501 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11568 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| a3677b16-8549-44c9-9a1b-adc2457b5369 | Efeitos adversos de outros parasimpaticomiméticos [colinérgicos] | Y511 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11573 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |